• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Bariatric surgery beneficial in type-2 diabetes, similar in cost to conventional treatment

byMelissa McCoyandStefan Trela
September 30, 2015
in Chronic Disease, Endocrinology, Surgery
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

 

1. Total health-care costs were higher for patients treated for obesity with bariatric surgery vs. conventional treatment if the patients were euglycemic or prediabetic prior to intervention.

2. However, total health-care costs were not significantly different for patients treated for obesity with bariatric surgery vs. conventional treatment if the patients were diabetic prior to intervention.

Evidence Rating Level: 1 (Excellent)

Study Rundown: Severely obese patients have difficulty losing weight through lifestyle changes, however, bariatric surgery has been shown to sustain weight loss and improve or eliminate type-2 diabetes in most patients. This study assessed health-care costs in patients with obesity that underwent bariatric surgery or were treated conventionally. 4,030 patients in Sweden were allotted to subgroups according to pre-intervention glycemic status (eugylcemic, prediabetes, or type-2 diabetes) and followed for a period of 15 years. Data for each patient on prescription drug costs, inpatient, and outpatient visits was retrieved from national registers and compared by intervention type (surgical vs. conventional) and pre-intervention glycemic status.

Drug costs were not significantly different in the surgery and conventional treatment groups for the euglycemic subgroup, but were lower in the surgery group for the prediabetes and the diabetes subgroups. Inpatient costs were higher for all patient subgroups treated with surgery compared to conventional treatment for obesity. No significant differences in outpatient costs were observed for any subgroup. Total health-care costs were higher for patients treated with surgery in the euglycemic and prediabetes subgroups, but was shown to have no significant difference for patients with diabetes. These cost findings support the prioritization of treatment of obesity with bariatric surgery for patients with diabetes. Though this study was limited by non-randomization, it was the first to assess obesity treatment costs according to pre-intervention glucose status.

Click to read the study in The Lancet Diabetes and Endocrinology

RELATED REPORTS

Metformin use may decrease risk of osteoarthritis development

Spirituality may help patients with weight management after bariatric surgery

Sodium-glucose co-transporter-2 inhibitors may decrease risk of in-stent thrombosis

Relevant Reading Bariatric Surgery and Prevention of Type 2 Diabetes in Swedish Obese Subjects

In-Depth [prospective cohort]: This study assessed health-care costs for patients treated for obesity (BMI ≥ 34 in men and ≥ 38 in women) with either conventional treatment (lifestyle intervention, behavior modification, or no intervention) or bariatric surgery. In Sweden, 4,030 patients (aged 37-60 years) were followed for 15 years in subgroups according to pre-intervention glycemic status (2,836 eugylcemic, 591 prediabetes, and 603 type-2 diabetes). Cost data for prescription drugs and for inpatient and outpatient visits for each patient was retrieved from questionnaires, the Swedish Prescribed Drug Register, and the Swedish National Patient Register.

Drug costs were not significantly different in the surgery and conventional treatment groups for the euglycemic subgroup (surgery US$10,511 vs. conventional treatment $10,680; adjusted mean difference -$225 [95% CI -2,080 to 1,631]; p=0.812), but were lower in the surgery group for prediabetes ($10,194 vs. $13,186; -$3,329 [-5,722 to -937]; p=0.007), and diabetes ($14,346 vs. $19,511; -$5,487 [–7,925 to –3,049]; p<0.0001) subgroups. Inpatient costs were higher for all patient subgroups treated with surgery compared to conventional treatment for obesity (euglycaemic ($51,225 vs. $25,313; $22,931 [19,001–26,861]; p<0.0001), prediabetes ($58,699 vs. $32,861; $27,152 [18,736–35,568]; p<0.0001), and diabetes ($61,569 vs. $47,569; 18,697 [9,992–27, 402]; p<0.0001). No significant differences in outpatient costs were observed for any subgroup. Total health-care costs were higher for patients treated with surgery in the euglycemic ($71, 059 vs. $45,542; $22,390 [17,358–27,423]; p<0.0001) and prediabetes ($78,151 vs. $54,864; $26,292 [16,738–35,845]; p<0.0001) subgroups, but was shown to have no significant difference for patients with diabetes ($88,572 vs. $79,967; $9,081 [–1,419 to 19,581]; p=0.090).

Image: PD

©2015 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: bariatric surgerydiabetesobesity
Previous Post

Cognitive behavioral therapy effective for depression but not self-care in heart failure

Next Post

Novel links identified between genetics, lung function and smoking behavior

RelatedReports

Physical therapy reduces pain in adults with knee osteoarthritis
Chronic Disease

Metformin use may decrease risk of osteoarthritis development

March 30, 2023
Increasing maternal BMI linked to higher risk of cerebral palsy
Chronic Disease

Spirituality may help patients with weight management after bariatric surgery

March 29, 2023
Endocrinology

Sodium-glucose co-transporter-2 inhibitors may decrease risk of in-stent thrombosis

March 24, 2023
2MM Podcast

The 2 Minute Medicine Podcast Episode 11

March 23, 2023
Next Post
Lung cancer screening may lower motivation for smoking cessation

Novel links identified between genetics, lung function and smoking behavior

Brodalumab effective in treating active psoriatic arthritis

Anti-interleukin-17A therapy shows promise in psoriatic arthritis

Blood pressure variability associated with cardiovascular disease and mortality

Cardiac risk factors more prevalent in obese children

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Childhood maltreatment may cause mental health problems
  • #VisualAbstract: Hydrochlorothiazide does not impact risk of kidney-stone recurrence
  • Metformin use may decrease risk of osteoarthritis development
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options